Single Ascending Dose Study to Assess the Safety, Tolerability and Pharmacokinetics of MMV371 LAI in Healthy Participants
Clinical trial NCT06558643 · COMPLETED
Trial details
- NCT number
- NCT06558643
- Sponsor
- Medicines for Malaria Venture
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-27
- Primary completion
- 2025-09-03
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.